BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis

The EPIC Consortium

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1 Citationer (Scopus)

Abstrakt

Death from sepsis in the neonatal period remains a serious threat for millions. Within 3 days of administration, bacille Calmette-Guérin (BCG) vaccination can reduce mortality from neonatal sepsis in human newborns, but the underlying mechanism for this rapid protection is unknown. We found that BCG was also protective in a mouse model of neonatal polymicrobial sepsis, where it induced granulocyte colony-stimulating factor (G-CSF) within hours of administration. This was necessary and sufficient to drive emergency granulopoiesis (EG), resulting in a marked increase in neutrophils. This increase in neutrophils was directly and quantitatively responsible for protection from sepsis. Rapid induction of EG after BCG administration also occurred in three independent cohorts of human neonates.
OriginalsprogEngelsk
TidsskriftScience Translational Medicine
Vol/bind12
Udgave nummer542
Sider (fra-til)eaax4517
ISSN1946-6234
DOI
StatusUdgivet - 6 maj 2020
Udgivet eksterntJa

Fingeraftryk Dyk ned i forskningsemnerne om 'BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater